| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |